Cholangiocarcinoma  	Cholangiocarcinoma  	 NNP	B-NP
Heterogeneity  	Heterogeneity  	 NNP	I-NP
Revealed  	Revealed  	 NNP	O
by  	by  	 IN	O
Multigene  	Multigene  	 NNP	B-NP
Mutational  	Mutational  	 NNP	I-NP
Profiling 	Profiling 	 NNP	O
:  	:  	 :	O
Clinical  	Clinical  	 NNP	O
and  	and  	 CC	O
Prognostic  	Prognostic  	 NNP	O
Relevance  	Relevance  	 NNP	O
in  	in  	 IN	O
Surgically  	Surgically  	 NNP	O
Resected  	Resected  	 NNP	B-NP
Patients  	Patients  	 NNPS	I-NP
Cholangiocarcinoma  	Cholangiocarcinoma  	 NNP	I-NP
can  	can  	 MD	O
be  	be  	 VB	O
classified  	classified  	 VBN	O
in  	in  	 IN	O
intrahepatic  	intrahepatic  	 JJ	B-NP
cholangiocarcinoma  	cholangiocarcinoma  	 NNS	I-NP
( 	( 	 -LRB-	O
ICC 	ICC 	 NNP	B-NP
)  	)  	 -RRB-	O
and  	and  	 CC	O
perihilar  	perihilar  	 JJ	B-NP
cholangiocarcinoma  	cholangiocarcinoma  	 NNS	I-NP
( 	( 	 -LRB-	O
PCC 	PCC 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
PCC  	PCC  	 NNP	B-NP
includes  	includes  	 VBZ	O
two  	two  	 CD	O
different  	different  	 JJ	O
forms 	forms 	 NNS	O
:  	:  	 :	O
extrahepatic  	extrahepatic  	 CD	B-NP
( 	( 	 -LRB-	O
EH 	EH 	 NNP	B-NP
)  	)  	 -RRB-	O
PCC 	PCC 	 NNP	B-NP
,  	,  	 ,	O
which  	which  	 WDT	O
arises  	arises  	 VBZ	O
from  	from  	 IN	O
the  	the  	 DT	O
perihilar  	perihilar  	 JJ	B-NP
EH  	EH  	 NNP	I-NP
large  	large  	 JJ	O
ducts 	ducts 	 NNS	O
,  	,  	 ,	O
and  	and  	 CC	O
intrahepatic  	intrahepatic  	 NNS	B-NP
( 	( 	 -LRB-	O
IH 	IH 	 NNP	B-NP
)  	)  	 -RRB-	O
PCC 	PCC 	 NNP	B-NP
,  	,  	 ,	O
in  	in  	 IN	O
which  	which  	 WDT	O
a  	a  	 DT	O
significant  	significant  	 JJ	O
liver  	liver  	 NN	O
mass  	mass  	 NN	O
invades  	invades  	 VBZ	O
the  	the  	 DT	O
perihilar  	perihilar  	 JJ	B-NP
bile  	bile  	 JJ	I-NP
ducts 	ducts 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
we  	we  	 PRP	O
investigated  	investigated  	 VBD	O
the  	the  	 DT	O
molecular  	molecular  	 JJ	B-NP
profile  	profile  	 NN	I-NP
and  	and  	 CC	O
molecular  	molecular  	 JJ	B-NP
prognostic  	prognostic  	 JJ	I-NP
factors  	factors  	 NNS	I-NP
in  	in  	 IN	O
EH-PCC 	EH-PCC 	 NNP	B-NP
,  	,  	 ,	O
IH-PCC 	IH-PCC 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
ICC  	ICC  	 NNP	B-NP
submitted  	submitted  	 VBD	O
to  	to  	 TO	O
curative  	curative  	 VB	B-NP
surgery 	surgery 	 NN	I-NP
.  	.  	 .	O
Ninety-one  	Ninety-one  	 JJ	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
cholangiocarcinoma  	cholangiocarcinoma  	 NNS	B-NP
( 	( 	 -LRB-	O
38  	38  	 CD	O
EH-PCC 	EH-PCC 	 NN	B-NP
,  	,  	 ,	O
18  	18  	 CD	O
IH-PCC 	IH-PCC 	 NN	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
35  	35  	 CD	O
ICC 	ICC 	 NNP	B-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
curative  	curative  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
in  	in  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
tertiary  	tertiary  	 JJ	B-NP
hepatobiliary  	hepatobiliary  	 JJ	I-NP
surgery  	surgery  	 NN	I-NP
referral  	referral  	 NN	I-NP
center  	center  	 NN	I-NP
were  	were  	 VBD	O
assessed  	assessed  	 VBN	O
for  	for  	 IN	O
mutational  	mutational  	 JJ	B-NP
status  	status  	 NN	I-NP
in  	in  	 IN	O
56  	56  	 CD	O
cancer-related  	cancer-related  	 JJ	O
genes 	genes 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
most  	most  	 RBS	O
frequently  	frequently  	 RB	O
mutated  	mutated  	 JJ	B-NP
genes  	genes  	 NNS	I-NP
in  	in  	 IN	O
EH-PCC  	EH-PCC  	 NNP	B-NP
were  	were  	 VBD	O
KRAS  	KRAS  	 NNP	B-NP
( 	( 	 -LRB-	O
47.4  	47.4  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
TP53  	TP53  	 NNP	B-NP
( 	( 	 -LRB-	O
23.7  	23.7  	 NNP	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
and  	and  	 CC	O
ARID1A  	ARID1A  	 NNP	O
( 	( 	 -LRB-	O
15.8  	15.8  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
in  	in  	 IN	O
IH-PCC  	IH-PCC  	 NNP	B-NP
were  	were  	 VBD	O
KRAS  	KRAS  	 NNP	B-NP
( 	( 	 -LRB-	O
22.2  	22.2  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
PBRM1  	PBRM1  	 NNP	B-NP
( 	( 	 -LRB-	O
16.7  	16.7  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
PIK3CA  	PIK3CA  	 NNP	O
( 	( 	 -LRB-	O
16.7  	16.7  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
;  	;  	 :	O
and  	and  	 CC	O
in  	in  	 IN	O
ICC  	ICC  	 NNP	B-NP
were  	were  	 VBD	O
IDH1  	IDH1  	 CD	B-NP
( 	( 	 -LRB-	O
17.1  	17.1  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
NRAS  	NRAS  	 NNP	B-NP
( 	( 	 -LRB-	O
17.1  	17.1  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
and  	and  	 CC	O
BAP1  	BAP1  	 NNP	B-NP
( 	( 	 -LRB-	O
14.3  	14.3  	 NNP	O
% 	% 	 NN	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
ALK 	ALK 	 NNP	B-NP
,  	,  	 ,	O
IDH1 	IDH1 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
TP53  	TP53  	 CD	B-NP
genes  	genes  	 NNS	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
EH-PCC  	EH-PCC  	 NNP	B-NP
( 	( 	 -LRB-	O
p   	p   	 NNP	O
< 	< 	 SYM	O
 0.001 	 0.001 	 NNP	O
,  	,  	 ,	O
p = 0.043 	p = 0.043 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
p = 0.019 	p = 0.019 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mutation  	Mutation  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
TP53  	TP53  	 JJ	B-NP
gene  	gene  	 NN	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
IH-PCC  	IH-PCC  	 NNP	B-NP
( 	( 	 -LRB-	O
p = 0.049 	p = 0.049 	 NNP	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
mutations  	mutations  	 NNS	O
in  	in  	 IN	O
ARID1A 	ARID1A 	 NNP	O
,  	,  	 ,	O
PIK3C2G 	PIK3C2G 	 NNP	O
,  	,  	 ,	O
STK11 	STK11 	 NNP	B-NP
,  	,  	 ,	O
TGFBR2 	TGFBR2 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
TP53  	TP53  	 CD	B-NP
genes  	genes  	 NNS	I-NP
was  	was  	 VBD	O
significantly  	significantly  	 RB	O
associated  	associated  	 VBN	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
ICC  	ICC  	 NNP	B-NP
( 	( 	 -LRB-	O
p = 0.012 	p = 0.012 	 NNP	O
,  	,  	 ,	O
p = 0.030 	p = 0.030 	 NNP	O
,  	,  	 ,	O
p = 0.030 	p = 0.030 	 NNP	O
,  	,  	 ,	O
p = 0.011 	p = 0.011 	 NNP	O
,  	,  	 ,	O
and  	and  	 CC	O
p = 0.011 	p = 0.011 	 NNP	O
,  	,  	 ,	O
respectively 	respectively 	 RB	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Mutational  	Mutational  	 JJ	B-NP
gene  	gene  	 NN	I-NP
profiling  	profiling  	 VBZ	O
identified  	identified  	 VBN	O
different  	different  	 JJ	O
gene  	gene  	 NN	B-NP
mutations  	mutations  	 NNS	I-NP
in  	in  	 IN	O
EH-PCC 	EH-PCC 	 NNP	B-NP
,  	,  	 ,	O
IH-PCC 	IH-PCC 	 NNP	B-NP
,  	,  	 ,	O
and  	and  	 CC	O
ICC 	ICC 	 NNP	B-NP
.  	.  	 .	O
Moreover 	Moreover 	 RB	O
,  	,  	 ,	O
our  	our  	 PRP$	O
study  	study  	 NN	O
reported  	reported  	 VBD	O
specific  	specific  	 JJ	O
prognostic  	prognostic  	 JJ	B-NP
genes  	genes  	 NNS	I-NP
that  	that  	 WDT	O
can  	can  	 MD	O
identify  	identify  	 VB	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
poor  	poor  	 JJ	O
prognosis  	prognosis  	 NN	O
after  	after  	 IN	O
curative  	curative  	 JJ	B-NP
surgery  	surgery  	 NN	I-NP
who  	who  	 WP	O
may  	may  	 MD	O
benefit  	benefit  	 VB	O
from  	from  	 IN	O
traditional  	traditional  	 JJ	O
or  	or  	 CC	O
target  	target  	 NN	B-NP
adjuvant  	adjuvant  	 NN	I-NP
treatments 	treatments 	 NNS	I-NP
.  	.  	 .	O
